Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06552741 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor 9 versions Re-verified since Dec 13, 2025, no change to tracked fieldsv37-v45
  2. Minor Site contact updatedv36
  3. Minor 6 versions Re-verified since Oct 30, 2024, no change to tracked fieldsv30-v35
  4. Minor Start date changed from estimate of Oct 1, 2024 to Sep 4, 2024v29
  5. Minor Start date: Sep 30, 2024 to Oct 1, 2024v28
Show 26 earlier versionsHide 26 earlier versions
  1. Minor Start date: Sep 29, 2024 to Sep 30, 2024v27
  2. Minor Start date: Sep 26, 2024 to Sep 29, 2024v26
  3. Minor Start date: Sep 25, 2024 to Sep 26, 2024v25
  4. Minor Start date: Sep 24, 2024 to Sep 25, 2024v24
  5. Minor Start date: Sep 19, 2024 to Sep 24, 2024v23
  6. Minor Start date: Sep 18, 2024 to Sep 19, 2024v22
  7. Minor Start date: Sep 17, 2024 to Sep 18, 2024v21
  8. Minor Start date: Sep 16, 2024 to Sep 17, 2024v20
  9. Minor Start date: Sep 15, 2024 to Sep 16, 2024v19
  10. Minor Start date: Sep 12, 2024 to Sep 15, 2024v18
  11. Minor Start date: Sep 11, 2024 to Sep 12, 2024v17
  12. Minor Start date: Sep 10, 2024 to Sep 11, 2024v16
  13. Minor Start date: Sep 9, 2024 to Sep 10, 2024v15
  14. Minor Start date: Sep 5, 2024 to Sep 9, 2024v14
  15. Minor Start date: Sep 4, 2024 to Sep 5, 2024v13
  16. Minor Start date: Sep 3, 2024 to Sep 4, 2024v12
  17. Minor Start date: Sep 2, 2024 to Sep 3, 2024v11
  18. Minor Start date: Sep 1, 2024 to Sep 2, 2024v10
  19. Minor Start date: Aug 29, 2024 to Sep 1, 2024v9
  20. Minor Start date: Aug 27, 2024 to Aug 29, 2024v8
  21. Minor Start date: Aug 26, 2024 to Aug 27, 2024v7
  22. Minor Start date: Aug 25, 2024 to Aug 26, 2024v6
  23. Minor Start date: Aug 22, 2024 to Aug 25, 2024v5
  24. Minor Start date: Aug 21, 2024 to Aug 22, 2024v4
  25. Minor Start date: Aug 20, 2024 to Aug 21, 2024v3
  26. Minor Start date: Aug 19, 2024 to Aug 20, 2024 Study title expanded, about 6 wordsv2 Show 1 more changeShow less
    • Study title expanded, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: People who will participate in research studies need to undergo proper screening, evaluation, and assessment (SEA). SEA helps keep those who participate in studies safe. It also helps ensure accurate study results. The National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) wants to screen people with alcohol and/or substance use disorders (ASUD) as well as people without ASUD for ongoing studies at NIDA in Baltimore, MD Objective: To screen people with or without ASUD for ongoing studies at NIDA. The ultimate goals are to learn why some people (1) use drugs; (2) stop using drugs; (3) use drugs but do not get addicted; and (4) never use drugs snd to develop ASUD treatments. Eligibility: People aged 18 years and older. They may (1) currently use nicotine, alcohol, opioids, cocaine, or other drugs; (2) no longer use them; or (3) have never used them. Design: Participants will have 1 screening visit that could last up to 8 hours. The visit may be split over more than 1 day. The duration of the screening may vary for each individual based on which studies they are interested in and screened for. The tests they undergo may vary and may include the following: * Physical exam. * Blood, saliva, and urine tests. * Breath samples that test for alcohol and carbon monoxide. * Test of heart function. * Smell test that measures sense of smell. * Tests of memory, attention, and thinking. * Mental health evaluation. * Mock magnetic resonance imaging (MRI) scan. * Questionnaires about alcohol and other drug use, mental health, medical history, and life in general.
Trial Details
NCT Number NCT06552741
Lead Sponsor National Institute on Drug Abuse (NIDA)
Conditions Substance Use Disorder, Alcohol Use Disorder
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov